Marker Therapeutics Inc expected to post a loss of 100 cents a share - Earnings Preview

Marker Therapeutics

13/03/2023 11:13

* Marker Therapeutics Inc  MRKR.OQ   MRKR.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 15
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Marker Therapeutics
Inc
is for a loss of 100 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Marker
Therapeutics Inc is $40​, above​ its last closing price
of $1.86. ​​​

This summary was machine generated March 13 at 11:13 GMT.  All
figures in US dollars  unless otherwise stated